P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH...

por Carlostella, C., Lahn, M., Hammett, T., van der Veen, L., Johnson, Z., Pickering, C., Santoro, A.
Publicado 2022

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors

por Deken, M.A., Niewola-Staszkowska, K., Peyruchaud, O., Mikulčić, N., Antolić, M., Shah, P., Cheasty, A., Tagliavini, A., Nizzardo, A., Pergher, M., Ziviani, L., Milleri, S., Pickering, C., Lahn, M., van der Veen, L., Di Conza, G., Johnson, Z.
Publicado 2023